Implant assembly, wrapping device and manufacturing method thereof

By wrapping the implanted medical device and loading anti-infective drugs, the problem of poor compatibility with human tissues and risk of infection is solved, and faster recovery and higher safety is achieved.

CN118949271APending Publication Date: 2024-11-15SPARKLE MEDICAL EQUIP (SHANGHAI) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411031340.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Due to the complex structure, smooth surface or charged characteristics of existing implantable medical devices, poor compatibility with human tissues and easy displacement, increasing postoperative recovery time and infection risk.

Method used

A wrapping device is designed with the housing cavity used to wrap an implantable medical device, providing protection and loading of anti-infective drugs, reducing direct contact, improving compatibility, and facilitating device replacement through resealable openings.

Benefits of technology

It improves the compatibility of the implanted device with human tissue, reduces the postoperative recovery time and infection risk, and enhances the stability and safety of the device.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118949271A_ABST
    Figure CN118949271A_ABST
Patent Text Reader

Abstract

The invention discloses an implantation assembly, a wrapping device and a manufacturing method thereof, the wrapping device comprises a shell, the shell is provided with an inner cavity, and the inner cavity is used for wrapping an implantable medical device. The implantable medical device is wrapped in the shell of the wrapping device, the wrapping device completely covers the surface of the implantable medical device, the problems caused by the characteristics of complex structure, smooth surface or electrification and the like of the implantable medical device are reduced, protection is provided for the implantable medical device, faults caused by corrosion of the implantable medical device are reduced, and the service life of the implantable medical device is prolonged. The compatibility of the whole device and surrounding tissues is improved, endothelial cells can quickly grow on the surface of the device, and the postoperative recovery time is shortened; the device is simple in structure, convenient to use and capable of assisting the implantable medical device to be anchored or supported on surrounding tissue, the implantable medical device can be safely fixed in the body of a patient, displacement of the implantable medical device at the implantation position of the human body is reduced, the use safety of the implantable medical device under the skin is improved, and the probability of infection is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical devices, and in particular to an implant component, a wrapping device and a manufacturing method thereof. Background Art

[0002] Cardiac implantable electronic devices are one of the important means of treating heart disease. Every year, about 1.5 million patients worldwide receive implantation of such devices. In addition to cardiac implantable electronic devices, there are also implantable chemotherapy pumps, implantable pain pumps, skull patches, implantable continuous blood glucose meters, implantable pulse generators, implantable neurostimulators and other implantable medical devices, and the annual usage is also very considerable.

[0003] However, these implantable medical devices usually have complex structures, smooth or charged surfaces, which make them less compatible with surrounding tissues and are not conducive to the rapid growth of endothelial cells on their surfaces, thus increasing the time of postoperative recovery. In addition, they are easy to shift in the human body, increasing the risk of using implantable medical devices under the skin. If the implantable medical device is charged, the body's body fluids may corrode its charged parts, causing them to malfunction.

[0004] In addition, despite various antibiotic precautions taken during the operation, there is still a risk of infection, which is a major complication of this implant surgery. Infection may seriously affect the patient's health status, increase the complexity and cost of treatment, and prolong the recovery period. Traditional treatment methods usually focus on postoperative antibiotic treatment or surgical treatment of the infected site, but these methods often cannot completely solve the infection problem and may bring additional risks. Summary of the invention

[0005] The technical problem to be solved by the present invention is to overcome the defects in the prior art of implantable medical devices with complex structures, smooth surfaces or electrical charges, poor compatibility with surrounding tissues, easy displacement in the human body, easy to cause patients' postoperative recovery time to be prolonged, increased risk of subcutaneous use and prone to infection, and to provide an implant component, a wrapping device and a manufacturing method thereof.

[0006] The present invention solves the above technical problems through the following technical solutions:

[0007] A wrapping device comprises: a shell having an inner cavity, and the inner cavity is used for wrapping an implantable medical device.

[0008] In this scheme, by wrapping the implantable medical device in the shell of the wrapping device, the wrapping device completely covers the surface of the implantable medical device, thereby reducing the direct contact between the implantable medical device and the surrounding tissues of the human body, reducing the problems caused by the complex structure, smooth surface or charged surface of the implantable medical device, and providing protection for the implantable medical device to reduce corrosion and failure, thereby improving the compatibility of the entire device with surrounding tissues, facilitating the rapid growth of endothelial cells on the surface of the wrapping device, and reducing the time for postoperative recovery.

[0009] Moreover, wrapping the implantable medical device with a wrapping device can help the implantable medical device to be anchored or supported in the surrounding tissues, and can safely fix the implantable medical device in the patient's body, reduce the displacement of the implantable medical device at the implantation site in the human body, improve the safety of subcutaneous use of the implantable medical device, and reduce the probability of infection.

[0010] In addition, when the outer surface of an implantable medical device is made of a heat-conducting material such as metal, this heat-conducting material is easily affected by the ambient temperature and produces a large temperature difference with the human body, which will reduce the comfort and safety of the human body. By wrapping such an implantable medical device with a wrapping device, the temperature impact of the external environment on the implantable medical device can be isolated, the patient's comfort and safety can be improved, the stability of the implanted position can be enhanced, and the risk of postoperative complications can be reduced.

[0011] Preferably, the shell is loaded with anti-infection drugs.

[0012] In this solution, after the wrapping device is implanted in the human body, since anti-infection drugs are loaded on the shell, these anti-infection drugs can be continuously released to the surrounding tissues after the wrapping device is implanted in the human body, thereby effectively preventing or reducing the risk of surgical site infection and improving the safety of the implantable medical device in the patient's body.

[0013] Preferably, the housing comprises an opening communicating with the inner cavity, wherein the opening is used for inserting the implantable medical device, and the opening is resealable.

[0014] In this solution, medical staff can open or close the resealable opening as needed, so as to conveniently load or remove the implantable medical device into or from the packaging device. When the implantable medical device fails in the human body or needs to be replaced, medical staff can replace only the implantable medical device through the opening without reimplanting the entire packaging device. In this way, only a smaller incision is needed to complete the replacement, which greatly reduces the surgical wound and reduces the risk of surgery. Moreover, a smaller incision means a shorter recovery time for patients after surgery, reducing the risk of postoperative infection.

[0015] Preferably, the opening is resealable by a self-sealing strip, a self-sealing clip or bonding.

[0016] In this solution, the self-sealing strip is used, which is easy to operate and can provide a reliable sealing effect. The self-sealing clip is used to fix the edges of the opening together by a clip or a clamp, which does not require additional material costs and is low in cost, and can also provide a reliable sealing effect. The bonding method uses materials such as medical glue or tape to firmly bond the edges of the opening together, providing a strong sealing effect.

[0017] Preferably, the shell is a single-layer or multi-layer mesh or film. In this solution, the mesh or film is specifically a textile, a woven product, a non-woven product, an extruded product, an injection-molded product, an electrostatic textile or a three-dimensional printed product.

[0018] Preferably, the shell comprises an inner layer and an outer layer;

[0019] The inner layer of the shell is made of anti-adhesion material;

[0020] And / or, the outer layer of the shell is made of a material with good biocompatibility.

[0021] In this solution, the inner layer is made of anti-adhesion material, which can effectively reduce the penetration of tissue or tissue fluid into the shell, reduce unnecessary inflammation, adhesion or deposition, thereby reducing unnecessary adhesion with the implanted medical device, helping to maintain the function of the implanted medical device, and easily open the packaging device when needed, thereby facilitating the replacement of the implanted medical device.

[0022] In addition, the outer layer is made of a material with good biocompatibility, which makes it easier for the outer layer material to adhere to the surrounding tissue or tissue fluid, which helps the shell to better integrate with the surrounding environment, facilitates the rapid growth of endothelial cells on its surface, and completely covers the surface of the wrapping device, thereby improving its compatibility with the surrounding tissue and reducing the time for postoperative recovery.

[0023] Preferably, the anti-adhesion material used in the inner layer of the shell is at least one of polylactic acid, hydrogel, polytetrafluoroethylene, expanded polytetrafluoroethylene, polyethylene terephthalate, polyethylene, expanded polyethylene, polypropylene, hyaluronic acid, chitosan, or derivatives of the above materials;

[0024] And / or, the material with good biocompatibility used for the outer layer of the shell is specifically a mesh.

[0025] In this solution, a preferred material selection scheme of anti-adhesion materials and materials with good biocompatibility is provided.

[0026] Preferably, the anti-infective drug is one or more of penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, quinolones, rifamycins, lincosamides, glycylcyclines, chloramphenicol, glycopeptides, polymyxins, cyclolipopeptides, oxazolidinones, fosfomycins, sulfonamides, β-lactams, nitroimidazoles, furans, cephamycins, oxacephems, carbapenems, polyenes, pyrimidines, pyrroles, triazoles, echinocandins, non-steroidal anti-inflammatory drugs, glucocorticoids or immunosuppressants.

[0027] In this solution, the anti-infective drug can be adaptively adjusted according to the implantation position and implantation residence time of the wrapped implantable medical device.

[0028] The present invention also discloses an implant assembly, which comprises:

[0029] Implantable medical devices;

[0030] The above-mentioned wrapping device.

[0031] Preferably, the wrapping device matches the shape and size of the implantable medical device, and the implantable medical device is closely attached to the inner wall of the shell.

[0032] In the present scheme, by designing the wrapping device to match the shape and size of the implantable medical device, the stability and safety of the implantable medical device can be ensured. The matching shape and size can prevent the implantable medical device from shifting or swinging at the implantation position, thereby reducing discomfort after implantation and the risk of complications. The implantable medical device is tightly attached to the inner wall of the shell of the wrapping device, which helps to maintain the stability and fixation of the implantable medical device. Through close fit, the gap between the two can be reduced, preventing the invasion of bacteria or other microorganisms (such as anaerobic bacteria) and reducing the risk of infection.

[0033] Preferably, the implantable medical device is an implantable chemotherapy pump, an implantable pain pump, a skull patch, an implantable continuous blood glucose meter, an implantable pacemaker, an implantable pulse generator, an implantable defibrillator, an implantable neural stimulator, an implantable pulse generator, an implantable hypertension treatment device, a plastic surgery implant, a dental implant, an implantable artificial organ, a monitoring implant, a breast implant or an implantable intravenous infusion port.

[0034] In this scheme, the wrapping device can be used for any medical device that can be implanted subcutaneously, reducing the problems caused by the complex structure, smooth surface or electrical characteristics of the implantable medical device, and providing protection for the implantable medical device to reduce corrosion and failure, thereby improving the compatibility of the entire device with the surrounding tissues, facilitating the rapid growth of endothelial cells on the surface of the wrapping device, and reducing the time for postoperative recovery; and it can assist the implantable medical device in anchoring or supporting the surrounding tissues, and can safely fix the implantable medical device in the patient's body, reducing the displacement of the implantable medical device at the implantation site in the human body, and improving the safety of subcutaneous use of the implantable medical device, helping it to fight the inflammatory response of the medical device after implantation, and reducing or preventing the probability of infection after implantation.

[0035] The present invention also discloses a method for manufacturing the above-mentioned wrapping device, which comprises the steps of: mixing the shell with the anti-infection drug to make the shell, coating the anti-infection drug on the shell, absorbing the anti-infection drug on the shell by soaking, or adding the anti-infection drug to the shell by 3D printing.

[0036] In this scheme, the shell is made by blending the anti-infective drug with the shell to ensure the uniformity of the distribution of the anti-infective drug on the shell and to ensure that the entire shell surface has anti-infective properties; the anti-infective drug is evenly covered on the surface of the shell by coating, which is suitable for the prepared shell and can directly form a layer of anti-infective drug coating on the shell surface, with high flexibility; the prepared shell is soaked in the solution of the anti-infective drug by immersion adsorption, so that the anti-infective drug is added to the surface of the shell, and a layer of coating with anti-infective drugs can be directly formed on the shell surface, which has little effect on the performance of the shell; 3D printing technology is used to directly add the anti-infective drug to the shell during the manufacturing process of the shell, so that the drug is more evenly distributed on the shell. Among them, the anti-infective drug is loaded by blending and 3D printing, and the material of the shell contains the anti-infective drug evenly; the anti-infective drug is loaded by coating and immersion adsorption, and the anti-infective drug is located on the surface of the shell, and a layer of coating with anti-infective drugs can be directly formed on the surface of the shell, which has little effect on the performance of the shell.

[0037] The positive and progressive effects of the present invention are:

[0038] (1) By wrapping the implantable medical device in the shell of the wrapping device, the wrapping device completely covers the surface of the implantable medical device, thereby reducing the direct contact between the implantable medical device and the surrounding tissues of the human body, reducing the problems caused by the complex structure, smooth surface or charged characteristics of the implantable medical device, and providing protection for the implantable medical device to reduce corrosion and failure, thereby improving the compatibility of the entire device with the surrounding tissues, facilitating the rapid growth of endothelial cells on the surface of the wrapping device, and reducing the time for postoperative recovery.

[0039] (2) Wrapping the implantable medical device with a wrapping device can help anchor or support the implantable medical device in the surrounding tissue, thereby safely fixing the implantable medical device in the patient's body and reducing the displacement of the implantable medical device at the implantation site in the human body. It also improves the safety of subcutaneous use of the implantable medical device and reduces the probability of infection. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 This is a schematic diagram of the two-dimensional structure of the wrapping device of a preferred embodiment of the present invention (I).

[0041] Figure 2 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (II).

[0042] Figure 3 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (III).

[0043] Figure 4 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (IV).

[0044] Figure 5 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (V).

[0045] Figure 6 FIG6 is a schematic structural diagram of a two-dimensional shape of a wrapping device according to a preferred embodiment of the present invention.

[0046] Figure 7 Schematic diagram of the two-dimensional structure of the wrapping device of the preferred embodiment of the present invention (VII).

[0047] Figure 8 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (VIII).

[0048] Fig. 9 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (IX).

[0049] Fig.10 This is a schematic diagram of the two-dimensional structure of the wrapping device of a preferred embodiment of the present invention (X).

[0050] Fig.11 This is a schematic structural diagram of the two-dimensional shape of the wrapping device of a preferred embodiment of the present invention (XI).

[0051] Fig.12 This is a schematic structural diagram of the three-dimensional shape of a wrapping device according to a preferred embodiment of the present invention (I).

[0052] Fig.13 This is a schematic structural diagram of the three-dimensional shape of the wrapping device of a preferred embodiment of the present invention (II).

[0053] Fig.14 This is a schematic structural diagram of the three-dimensional shape of the wrapping device of a preferred embodiment of the present invention (III).

[0054] Fig.15 This is a schematic structural diagram of the three-dimensional shape of the wrapping device of a preferred embodiment of the present invention (IV).

[0055] Fig.16 This is a schematic structural diagram of the three-dimensional shape of the wrapping device of a preferred embodiment of the present invention (V).

[0056] Description of reference numerals:

[0057] Shell 1

[0058] Opening 2 DETAILED DESCRIPTION

[0059] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples.

[0060] like Figure 1-Figure 16 As shown, the present invention discloses an implant assembly, which includes a wrapping device and an implantable medical device (not shown in the figure), wherein the wrapping device includes: a shell 1, the shell 1 has an inner cavity, and the inner cavity is used to wrap the implantable medical device. By wrapping the implantable medical device in the shell 1 of the wrapping device, the wrapping device completely covers the surface of the implantable medical device, reducing the problems caused by the complex structure, smooth surface or charged characteristics of the implantable medical device, and providing protection for the implantable medical device to reduce corrosion and failure, improving the compatibility of the entire device with the surrounding tissue, facilitating the rapid growth of endothelial cells on the surface of the wrapping device, and reducing the time of postoperative recovery; and can assist the implantable medical device to anchor or support the surrounding tissue, and can safely fix the implantable medical device in the patient's body, reducing the displacement of the implantable medical device at the implantation site of the human body, and improving the safety of subcutaneous use of the implantable medical device, reducing the probability of infection.

[0061] Preferably, in this embodiment, the shell 1 is loaded with anti-infection drugs. In this embodiment, after the package device is implanted in the human body, since the anti-infection drugs are loaded on the shell 1, these anti-infection drugs can be continuously released to the surrounding tissues after the package device is implanted in the human body, thereby effectively preventing or reducing the risk of surgical site infection and improving the safety of the implantable medical device in the patient's body.

[0062] Of course, in other alternative embodiments, the shell 1 may not be loaded with anti-infection drugs, that is, the effect of protecting the implantable medical device is achieved by isolating the implantable medical device from surrounding tissues through the shell 1.

[0063] like Figure 1-Figure 16 As shown, the housing 1 includes an opening 2 connected to the inner cavity, and the opening 2 is used to insert the implantable medical device, and the opening 2 is resealable. Medical staff can open or close the resealable opening 2 as needed, so as to conveniently put the implantable medical device into or take it out of the package device. When the implantable medical device fails in the human body or needs to be replaced, the medical staff can replace only the implantable medical device through the opening 2 without re-implanting the entire package device. In this way, only a smaller incision is needed to complete the replacement, which greatly reduces the surgical wound and reduces the risk of surgery. Moreover, a smaller incision means that the patient's recovery time after surgery is shorter, reducing the risk of postoperative infection.

[0064] Specifically, the resealable manner of the opening 2 can be a self-sealing strip, a self-sealing clip or bonding. Among them, the self-sealing strip is easy to operate and can provide a reliable sealing effect. The self-sealing clip is used to fix the edges of the opening 2 together by a clip or a clamp, which does not require additional material costs, has a low cost, and can also provide a reliable sealing effect. The bonding method uses materials such as medical glue or tape to firmly bond the edges of the opening 2 together, providing a strong sealing effect.

[0065] Specifically, the housing 1 may be a multi-layer mesh or film. Of course, in other alternative embodiments, the housing 1 may also be a single-layer mesh or film. In this embodiment, the mesh or film may be a textile, a woven fabric, a non-woven fabric, an extruded product, an injection molded product, an electrostatic textile, or a three-dimensional printed product.

[0066] Specifically, the shell 1 includes an inner layer and an outer layer, the inner layer of the shell 1 is made of an anti-adhesion material, and the outer layer of the shell 1 is made of a material with good biocompatibility. The inner layer is made of an anti-adhesion material, which can effectively reduce the penetration of tissue or tissue fluid into the shell 1, reduce unnecessary inflammation, adhesion or deposition, thereby reducing unnecessary adhesion with the implanted medical device, helping to maintain the function of the implanted medical device, and making it easy to open the package device when needed, so as to facilitate the replacement of the implanted medical device; the outer layer is made of a material with good biocompatibility, so that the material of the outer layer is more likely to adhere to the surrounding tissue or tissue fluid, which helps the shell 1 to better integrate with the surrounding environment, facilitates the rapid growth of endothelial cells on its surface, completely covers the surface of the package device, improves its compatibility with the surrounding tissue, and reduces the time of postoperative recovery.

[0067] In this embodiment, the anti-adhesion material is at least one of polylactic acid, hydrogel, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), polyethylene terephthalate (PET), polyethylene (PE), expanded polyethylene (ePE), polypropylene, hyaluronic acid, chitosan, or derivatives of the above materials, but is not limited to the above materials. Any material that exists in the prior art and is relatively good in anti-adhesion can be selected as the inner layer of the shell 1.

[0068] Meanwhile, the material with good biocompatibility may be a mesh, but is not limited to a mesh. Any material that exists in the prior art and has relatively good biocompatibility may be selected as the outer layer of the shell 1 .

[0069] In this embodiment, the anti-infective drug is one or more of penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, quinolones, rifamycins, lincosamides, glycylcyclines, chloramphenicol, glycopeptides, polymyxins, cyclolipopeptides, oxazolidinones, fosfomycins, sulfonamides, β-lactams, nitroimidazoles, furans, cephamycins, oxacephems, carbapenems, polyenes, pyrimidines, pyrroles, triazoles, echinocandins, non-steroidal anti-inflammatory drugs, glucocorticoid drugs or immunosuppressants. Among them, the specific selection of the anti-infective drug can be adaptively adjusted according to the implantation position and implantation residence time of the encapsulated implantable medical device.

[0070] Specifically, the shape and size of the wrapping device match the shape and size of the implantable medical device, so that the implantable medical device can be closely attached to the inner wall of the shell. By designing the wrapping device to match the shape and size of the implantable medical device, the stability and safety of the implantable medical device can be ensured. The matching shape and size can prevent the implantable medical device from shifting or swinging at the implantation position, thereby reducing the discomfort after implantation and the risk of complications; the implantable medical device is closely attached to the inner wall of the shell of the wrapping device, which helps to maintain the stability and fixity of the implantable medical device. Through close fit, the gap between the two can be reduced, preventing the invasion of bacteria or other microorganisms (such as anaerobic bacteria) and reducing the risk of infection.

[0071] Specifically, Figure 1-Figure 11 As shown, the wrapping device can be a two-dimensional shape (flat, with a thickness much smaller than the length and width) of any one or more of a circle, an ellipse, a rectangle, a square, a rounded rectangle, a rounded square, a polygon, an irregular shape, or a combination of the above shapes. Figure 12-16As shown, the wrapping device is a three-dimensional shape of any one or more of a cylindrical shape, a cubic shape, a cuboid shape, and an irregular shape. By setting the shape of the wrapping device, it is convenient to achieve the purpose of matching the shape of the implantable medical device, so that the wrapping device and the implantable medical device fit more closely.

[0072] In this embodiment, the implantable medical device can be suitable for an implantable chemotherapy pump, an implantable pain pump, a skull patch, an implantable continuous blood glucose meter, an implantable pacemaker, an implantable pulse generator, an implantable defibrillator, an implantable neural stimulator, an implantable pulse generator, an implantable hypertension treatment device, a plastic surgery implant, a dental implant, an implantable artificial organ, a monitoring implant, a breast implant or an implantable intravenous infusion port. Of course, in other embodiments, the wrapping device can be used for any other medical device that can be implanted subcutaneously, reducing the problems caused by the complex structure, smooth surface or electrical characteristics of the implantable medical device, and providing protection for the implantable medical device to reduce corrosion and failure, thereby improving the compatibility of the entire device with the surrounding tissues, facilitating the rapid growth of endothelial cells on the surface of the wrapping device, and reducing the postoperative recovery time; and can assist the implantable medical device in anchoring or supporting the surrounding tissues, and can safely fix the implantable medical device in the patient's body, reducing the displacement of the implantable medical device at the implantation site in the human body, and improving the safety of subcutaneous use of the implantable medical device, helping it to fight the inflammatory response of the medical device after implantation, and reducing or preventing the probability of infection after implantation.

[0073] Taking skull patches as an example, existing skull patches are generally made of titanium plates. Since the surface of traditional titanium plates is relatively smooth, it is not conducive to the crawling and growth of endothelial cells on their surface. Moreover, in a space environment with low temperature, metal materials are easily affected by the ambient temperature and produce a large temperature difference with the human body. Patients will feel that the location where the skull patch is implanted is very cold, which will reduce the comfort and safety of the human body. Putting the skull patch into a wrapping device can solve the technical problems caused by its smooth surface and unstable temperature. By adopting materials with good biocompatibility that promote tissue growth, the crawling and growth of endothelial cells on the surface of the wrapping device can be promoted, and biocompatibility can be improved. At the same time, by wrapping this type of implantable medical device with a wrapping device, the wrapping device can also isolate the temperature impact of the external environment on the skull patch, improve the patient's comfort and safety, enhance the stability of the skull patch at the implantation position, and reduce the risk of postoperative complications.

[0074] In addition, in the case where the implantable medical device being wrapped is an electronic device, such as an implantable continuous blood glucose meter, an implantable pacemaker, an implantable pulse generator, an implantable defibrillator, an implantable neurostimulator, etc., wrapping the implantable medical device with a wrapping device can not only improve the compatibility of the implantable medical device with the surrounding tissues and avoid displacement of the implantable medical device at the implantation site in the human body, but also protect the electronic device from being corroded by the human body's tissue fluid and affecting its function and performance.

[0075] The present embodiment also discloses a method for manufacturing a wrapping device, which comprises the steps of: mixing the shell 1 with an anti-infective drug to produce the shell 1, coating the anti-infective drug on the shell 1, adsorbing the anti-infective drug on the shell 1 by soaking, or adding the anti-infective drug to the shell 1 by 3D printing.

[0076] In this solution, the shell 1 is made by blending the anti-infective drug with the shell 1, ensuring the uniformity of the distribution of the anti-infective drug on the shell 1 and ensuring that the entire surface of the shell 1 has anti-infective properties; the anti-infective drug is evenly covered on the surface of the shell 1 by coating, which is suitable for the prepared shell 1 and can directly form a layer of anti-infective drug coating on the surface of the shell 1, with high flexibility; the prepared shell 1 is soaked in the solution of the anti-infective drug by immersion adsorption, so that the anti-infective drug is added to the surface of the shell 1, and a layer of coating with anti-infective drugs can be directly formed on the surface of the shell 1, which has little effect on the performance of the shell 1; the anti-infective drug is directly added to the shell 1 during the manufacturing process of the shell 1 by 3D printing technology, so that the drug is more evenly distributed on the shell 1. Among them, the anti-infective drug is loaded by blending and 3D printing, and the material of the shell 1 contains the anti-infective drug evenly; the anti-infective drug is loaded by coating and immersion adsorption, and the anti-infective drug is located on the surface of the shell 1, and a layer of coating with anti-infective drugs can be directly formed on the surface of the shell 1, which has little effect on the performance of the shell 1.

[0077] Although the specific embodiments of the present invention are described above, it should be understood by those skilled in the art that this is only for illustration and the protection scope of the present invention is defined by the appended claims. Those skilled in the art may make various changes or modifications to these embodiments without departing from the principles and essence of the present invention, but these changes and modifications all fall within the protection scope of the present invention.

Claims

1. A wrapping device, characterized in that: It includes: The shell has an inner cavity, and the inner cavity is used to enclose the implantable medical device.

2. The wrapping device according to claim 1, characterized in that The housing is loaded with anti-infection drugs.

3. The wrapping device according to claim 1 or 2, characterized in that: The housing comprises an opening communicating with the inner cavity, wherein the opening is used for inserting the implantable medical device, and the opening is resealable.

4. The wrapping device according to claim 3, characterized in that: The opening can be resealed in a self-sealing strip, a self-sealing clip or bonding.

5. The wrapping device according to claim 1 or 2, characterized in that: The shell is a single-layer or multi-layer mesh or film; Preferably, the mesh or film is a textile, a woven product, a non-woven product, an extruded product, an injection molded product, an electrostatic textile or a three-dimensional printed product.

6. The wrapping device according to claim 1 or 2, characterized in that: The shell comprises an inner layer and an outer layer; The inner layer of the shell is made of anti-adhesion material; and / or, the outer layer of the shell is made of a material with good biocompatibility; Preferably, the anti-adhesion material used in the inner layer of the shell is at least one of polylactic acid, hydrogel, polytetrafluoroethylene, expanded polytetrafluoroethylene, polyethylene terephthalate, polyethylene, expanded polyethylene, polypropylene, hyaluronic acid, chitosan, or derivatives of the above materials; Preferably, and / or, the material with good biocompatibility used for the outer layer of the shell is specifically a mesh.

7. The wrapping device according to claim 2, characterized in that: The anti-infective drug is one or more of penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, quinolones, rifamycins, lincosamides, glycylcyclines, chloramphenicol, glycopeptides, polymyxins, cyclolipopeptides, oxazolidinones, fosfomycins, sulfonamides, β-lactams, nitroimidazoles, furans, cephamycins, oxacephems, carbapenems, polyenes, pyrimidines, pyrroles, triazoles, echinocandins, non-steroidal anti-inflammatory drugs, glucocorticoids or immunosuppressants.

8. An implant assembly, characterized in that: It includes: Implantable medical devices; A wrapping device as claimed in any one of claims 1 to 7.

9. The implant assembly according to claim 8, characterized in that The wrapping device matches the shape and size of the implantable medical device, and the implantable medical device is closely attached to the inner wall of the shell; And / or, the implantable medical device is an implantable chemotherapy pump, an implantable pain pump, a skull patch, an implantable continuous blood glucose meter, an implantable pacemaker, an implantable pulse generator, an implantable defibrillator, an implantable neurostimulator, an implantable pulse generator, an implantable hypertension treatment device, a plastic surgery implant, a dental implant, an implantable artificial organ, a monitoring implant, a breast implant or an implantable intravenous infusion port.

10. A method for manufacturing a wrapping device according to any one of claims 1 to 7, characterized in that: The method comprises the following steps: mixing a shell with an anti-infection drug to produce the shell, coating the anti-infection drug on the shell, adsorbing the anti-infection drug on the shell by soaking, or adding the anti-infection drug to the shell by 3D printing.